Design
Review
Authors
Loading...
No change to post-MI care warranted; leaves open fibrinolysis modulation as therapeutic target.
Key points are not available for this paper at this time.
Robert Hume (1958) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: